神经状态及扩展残疾状态量表（EDSS）计算与病例
Neurostatus and EDSS Calculation with Cases.
作者信息
Şen Sedat
机构信息
Neurology Department, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.
出版信息
Noro Psikiyatr Ars. 2018;55(Suppl 1):S80-S83. doi: 10.29399/npa.23412.
Abstract
Expanded Disability Status Scale (EDSS) is the most commonly used disability scale for multiple sclerosis (MS) patients. It provides effective and reliable evaluation at every stage of the disease. It is mainly based on the evaluation of functional systems. Neurostatus provides an up-to-date and improved basis for EDSS assessment.
摘要
扩展残疾状态量表（EDSS）是多发性硬化症（MS）患者最常用的残疾量表。它在疾病的各个阶段都能提供有效且可靠的评估。它主要基于功能系统的评估。神经状态为EDSS评估提供了最新且改进的依据。
相似文献
1
Neurostatus and EDSS Calculation with Cases.神经状态及扩展残疾状态量表（EDSS）计算与病例
Noro Psikiyatr Ars. 2018;55(Suppl 1):S80-S83. doi: 10.29399/npa.23412.
2
Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.电子神经状态-EDSS 提高了扩展残疾状况量表评估的质量：来自两项 3 期临床试验的经验。
Mult Scler. 2020 Jul;26(8):993-996. doi: 10.1177/1352458519845108. Epub 2019 May 7.
3
Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.神经状态电子评分提高了扩展残疾状况量表评估的一致性：概念验证研究。
Mult Scler. 2017 Apr;23(4):597-603. doi: 10.1177/1352458516657439. Epub 2016 Jul 11.
4
[The Expanded Disability Status Scale scoring in patients with multiple sclerosis].[多发性硬化症患者的扩展残疾状态量表评分]
Ideggyogy Sz. 2019 Sep 30;72(9-10):317-323. doi: 10.18071/isz.72.0317.
5
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌：其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.
6
MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.MS-CANE：一种用于多发性硬化症患者神经学评估的计算机辅助仪器：增强扩展残疾状态量表（EDSS）评估的可靠性
Mult Scler. 2000 Oct;6(5):355-61. doi: 10.1177/135245850000600511.
7
Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.扩展残疾状态量表和多发性硬化功能综合评分作为多发性硬化临床试验临床终点的评估：定量荟萃分析
Curr Med Res Opin. 2016 Dec;32(12):1969-1974. doi: 10.1080/03007995.2016.1222516. Epub 2016 Sep 7.
8
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.患者报告的扩展残疾状态量表工具的比较分析
Mult Scler. 2016 Sep;22(10):1349-58. doi: 10.1177/1352458515616205. Epub 2015 Nov 12.
9
Balance Testing in Multiple Sclerosis-Improving Neurological Assessment With Static Posturography?多发性硬化症中的平衡测试——利用静态姿势描记法改善神经学评估？
Front Neurol. 2020 Feb 26;11:135. doi: 10.3389/fneur.2020.00135. eCollection 2020.
10
On the origin of EDSS.关于扩展残疾状态量表（EDSS）的起源
Mult Scler Relat Disord. 2015 Mar;4(2):95-103. doi: 10.1016/j.msard.2015.02.003. Epub 2015 Feb 24.
引用本文的文献
1
Health-related quality of life of patients with multiple sclerosis in China: a national online survey.中国多发性硬化症患者的健康相关生活质量：一项全国性在线调查。
Health Qual Life Outcomes. 2025 Jul 9;23(1):70. doi: 10.1186/s12955-025-02376-w.
2
Correlations Between Disability Score, Optical Coherence Tomography and Microperimetry in Patients with Multiple Sclerosis.多发性硬化症患者残疾评分、光学相干断层扫描与微视野检查之间的相关性
Eye Brain. 2024 Nov 12;16:89-100. doi: 10.2147/EB.S469182. eCollection 2024.
3
Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years.顺磁环病变预示着在 10 年内更大的长期复发率和临床进展。
Mult Scler. 2024 Apr;30(4-5):535-545. doi: 10.1177/13524585241229956. Epub 2024 Feb 17.
4
The Potential Role of Fecal Microbiota Transplant in the Reversal or Stabilization of Multiple Sclerosis Symptoms: A Literature Review on Efficacy and Safety.粪便微生物群移植在逆转或稳定多发性硬化症状中的潜在作用：疗效与安全性的文献综述
Microorganisms. 2023 Nov 22;11(12):2840. doi: 10.3390/microorganisms11122840.
5
Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis.比较多发性硬化症和视神经脊髓炎患者中OX40的表达作为一种诊断方法。
Allergy Asthma Clin Immunol. 2023 Mar 10;19(1):19. doi: 10.1186/s13223-023-00772-9.
6
Leukocyte Telomere Length Predicts Severe Disability in Relapsing-Remitting Multiple Sclerosis and Correlates with Mitochondrial DNA Copy Number.白细胞端粒长度可预测复发缓解型多发性硬化症的严重残疾，并与线粒体 DNA 拷贝数相关。
Int J Mol Sci. 2023 Jan 4;24(2):916. doi: 10.3390/ijms24020916.
7
Coping Strategies Furthering Post-Traumatic Growth in Multiple Sclerosis: A Longitudinal Study.应对策略促进多发性硬化症的创伤后成长：一项纵向研究。
Int J Environ Res Public Health. 2022 Oct 4;19(19):12679. doi: 10.3390/ijerph191912679.
8
Brain MRI dataset of multiple sclerosis with consensus manual lesion segmentation and patient meta information.具有共识性手动病变分割和患者元信息的多发性硬化症脑MRI数据集。
Data Brief. 2022 Apr 7;42:108139. doi: 10.1016/j.dib.2022.108139. eCollection 2022 Jun.
9
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study.多发性硬化症患者的人格特征及其与焦虑和抑郁水平的相关性：一项横断面病例对照研究。
Brain Behav. 2022 May;12(5):e2596. doi: 10.1002/brb3.2596. Epub 2022 Apr 22.
10
Evaluation of the Psychometric Properties of the Health Assessment Questionnaire (HAQ) in a Population of Individuals With Multiple Sclerosis.健康评估问卷（HAQ）在多发性硬化症患者群体中的心理测量学特性评估。
Front Neurol. 2022 Mar 28;13:847786. doi: 10.3389/fneur.2022.847786. eCollection 2022.
本文引用的文献
1
Origin of DSS: to present the plan.决策支持系统的起源：展示该计划。
Mult Scler. 2007 Jan;13(1):120-3. doi: 10.1177/1352458506071584.
2
On the evaluation of disability in multiple sclerosis.关于多发性硬化症残疾情况的评估。
Neurology. 1961 Aug;11:686-94. doi: 10.1212/wnl.11.8.686.
3
A new scale for evaluating disability in multiple sclerosis.一种评估多发性硬化症残疾程度的新量表。
Neurology. 1955 Aug;5(8):580-3. doi: 10.1212/wnl.5.8.580.
4
Quantification of impairment in MS: discussion of the scales in use.多发性硬化症损伤的量化：对现行量表的讨论。
Mult Scler. 1999 Aug;5(4):216-9. doi: 10.1177/135245859900500404.
5
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).评估多发性硬化症的神经功能损伤：扩展残疾状态量表（EDSS）
Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
6
Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.一项多发性硬化症临床试验中扩展残疾状态量表（EDSS）和功能系统（FS）的评分者间变异性。加拿大合作多发性硬化症研究组。
Neurology. 1990 Jun;40(6):971-5. doi: 10.1212/wnl.40.6.971.
Zotero 插件